Interact to see
Advertisement
Advertisement
DSMDX vs PMAQX
DSMDX vs PMAQX Comparison
Open Charts DSMDX vs PMAQX
Driehaus Small/Mid Cap Growth
Price$17.45
Change-$0.19 (-1.08%)
VolumeN/A
Net Assets60.05M
DSMDX vs PMAQX Comparison Chart
Loading...
View a ticker or compare two or three
VS
VS
FUNDAMENTALS
Fundamentals
PMAQX has more cash in the bank: 30.6B vs. DSMDX (60.1M). DSMDX pays higher dividends than PMAQX: DSMDX (0.37) vs PMAQX (0.19). DSMDX was incepted earlier than PMAQX: DSMDX (5 years) vs PMAQX (9 years). DSMDX (0.84) is less costly to investors than PMAQX (0.59). DSMDX is a more actively managed with annual turnover of: 129.00 vs. PMAQX (10.50). PMAQX has a lower initial minimum investment than DSMDX: PMAQX (0) vs DSMDX (10000). PMAQX annual gain was more profitable for investors over the last year : 10.62 vs. DSMDX (-1.81). PMAQX return over 5 years is better than : 56.82 vs. DSMDX (51.98).
| DSMDX | PMAQX | DSMDX / PMAQX | |
| Total Expense Ratio | 0.80 | 0.59 | 136% |
| Annual Report Gross Expense Ratio | 0.84 | 0.59 | 142% |
| Fund Existence | 5 years | 9 years | - |
| Gain YTD | -7.574 | 2.039 | -371% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 10000 | 0 | - |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 60.1M | 30.6B | 0% |
| Annual Yield % from dividends | 0.37 | 0.19 | 191% |
| Returns for 1 year | -1.81 | 10.62 | -17% |
| Returns for 3 years | 39.84 | 50.92 | 78% |
| Returns for 5 years | 51.98 | 56.82 | 91% |
| Returns for 10 years | N/A | N/A | - |
View a ticker or compare two or three
VS
VS
Interact to see
Advertisement
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| FDNI | 33.29 | N/A | N/A |
| First Trust Dow Jones Intl Intnt ETF | |||
| JAAA | 50.65 | -0.01 | -0.02% |
| Janus Henderson AAA CLO ETF | |||
| GHYG | 45.45 | -0.15 | -0.32% |
| iShares US & Intl High Yield Corp Bd ETF | |||
| BNDW | 68.77 | -0.23 | -0.33% |
| Vanguard Total World Bond ETF | |||
| HQL | 12.85 | -0.13 | -1.00% |
| abrdn Life Sciences Investors | |||